A 62-year-old with NSTEMI is stabilized. Which secondary prevention lipid target/strategy is correct per US guidance?...

Question

A 62-year-old with NSTEMI is stabilized. Which secondary prevention lipid target/strategy is correct per US guidance?

Accepted Answer

Use high-intensity statin and consider nonstatin if LDL-C >=70 mg/dL in very high-risk ASCVD

Answer

Add ezetimibe if LDL-C >=100 mg/dL on moderate-intensity statin

Answer

Avoid statins if age >60 due to adverse effects

Answer

Start PCSK9 inhibitor first-line before statin

Answer

Use niacin to raise HDL as primary strategy

us-abim MCQ (SBA): ASCVD Lipid Management